Found: 3
Select item for more details and to access through your institution.
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.
- Published in:
- Journal of Pain Research, 2019, v. 12, p. 3113, doi. 10.2147/JPR.S217563
- By:
- Publication type:
- Article
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 5, p. 639, doi. 10.1002/cpdd.750
- By:
- Publication type:
- Article
Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article